Quadrature Capital’s Exact Sciences EXAS Stock Holding History

Quadrature Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,390	Closed	-$295K	–	1375
2025 Q3	$295K	Buy	+5,390	New	+$269K	﹤0.01%	675

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Quadrature Capital's EXAS Position: Q4 2025 in Review

Quadrature Capital sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 5,390 shares — an estimated $295K sold.

Quadrature Capital first reported a position in EXAS in Q3 2025 and held it in 1 quarter. The position peaked at $295K in Q3 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

Quadrature Capital reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
Quadrature Capital sold 5,390 Exact Sciences shares in Q4 2025, an estimated $295K.
Quadrature Capital first reported a position in Exact Sciences in Q3 2025 and held it in 1 quarter.
Quadrature Capital's Exact Sciences position peaked at $295K in Q3 2025.
711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.